Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
Victor L. Villemagne, Samantha Burnham, Pierrick Bourgeat, et al.
The Lancet Neurology (2013) Vol. 12, Iss. 4, pp. 357-367
Closed Access | Times Cited: 1987

Showing 1-25 of 1987 citing articles:

NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack, David A. Bennett, Kaj Blennow, et al.
Alzheimer s & Dementia (2018) Vol. 14, Iss. 4, pp. 535-562
Open Access | Times Cited: 7701
Dementia prevention, intervention, and care
Gill Livingston, Andrew Sommerlad, Vasiliki Orgeta, et al.
The Lancet (2017) Vol. 390, Iss. 10113, pp. 2673-2734
Open Access | Times Cited: 5468
The amyloid hypothesis of Alzheimer's disease at 25 years
Dennis J. Selkoe, John Hardy
EMBO Molecular Medicine (2016) Vol. 8, Iss. 6, pp. 595-608
Open Access | Times Cited: 5110
2016 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2016) Vol. 12, Iss. 4, pp. 459-509
Closed Access | Times Cited: 4976
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
Jeff Sevigny, Ping Chiao, Thierry Bussière, et al.
Nature (2016) Vol. 537, Iss. 7618, pp. 50-56
Closed Access | Times Cited: 2549
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
Frank Jessen, Rebecca E. Amariglio, Martin P.J. van Boxtel, et al.
Alzheimer s & Dementia (2014) Vol. 10, Iss. 6, pp. 844-852
Open Access | Times Cited: 2392
2019 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2019) Vol. 15, Iss. 3, pp. 321-387
Closed Access | Times Cited: 2165
2020 Alzheimer's disease facts and figures
In this phase, individuals have measurable brain changes that indicate the earliest signs of Alzheimer's disease, but they have not yet developed symptoms such as memory loss. Examples of measurable brain changes …, et al.
Alzheimer s & Dementia (2020) Vol. 16, Iss. 3, pp. 391-460
Open Access | Times Cited: 2138
2023 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2023) Vol. 19, Iss. 4, pp. 1598-1695
Open Access | Times Cited: 1986
2022 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2022) Vol. 18, Iss. 4, pp. 700-789
Closed Access | Times Cited: 1961
2021 Alzheimer's disease facts and figures
In the past, was often used to describe the dementia phase of the disease. Today we know that dementia is only …, Adult Disease, et al.
Alzheimer s & Dementia (2021) Vol. 17, Iss. 3, pp. 327-406
Closed Access | Times Cited: 1910
2018 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2018) Vol. 14, Iss. 3, pp. 367-429
Closed Access | Times Cited: 1796
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway, Reisa A. Sperling, Nick C. Fox, et al.
New England Journal of Medicine (2014) Vol. 370, Iss. 4, pp. 322-333
Open Access | Times Cited: 1791
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
Bruno Dubois, Harald Hampel, Howard Feldman, et al.
Alzheimer s & Dementia (2016) Vol. 12, Iss. 3, pp. 292-323
Open Access | Times Cited: 1633
Microglia in Alzheimer’s disease
David V. Hansen, Jesse E. Hanson, Morgan Sheng
The Journal of Cell Biology (2017) Vol. 217, Iss. 2, pp. 459-472
Open Access | Times Cited: 1560
2015 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2015) Vol. 11, Iss. 3, pp. 332-384
Closed Access | Times Cited: 1545
Defeating Alzheimer's disease and other dementias: a priority for European science and society
Bengt Winblad, Philippe Amouyel, Sandrine Andrieu, et al.
The Lancet Neurology (2016) Vol. 15, Iss. 5, pp. 455-532
Open Access | Times Cited: 1490
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Mathias Jucker, Lary C. Walker
Nature (2013) Vol. 501, Iss. 7465, pp. 45-51
Open Access | Times Cited: 1478
Alzheimer's disease
Colin L. Masters, Randall J. Bateman, Kaj Blennow, et al.
Nature Reviews Disease Primers (2015) Vol. 1, Iss. 1
Closed Access | Times Cited: 1426
Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia
Willemijn J. Jansen, Rik Ossenkoppele, Dirk L. Knol, et al.
JAMA (2015) Vol. 313, Iss. 19, pp. 1924-1924
Open Access | Times Cited: 1372
2017 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2017) Vol. 13, Iss. 4, pp. 325-373
Closed Access | Times Cited: 1267
PET Imaging of Tau Deposition in the Aging Human Brain
Michael Schöll, Samuel N. Lockhart, Daniel R. Schonhaut, et al.
Neuron (2016) Vol. 89, Iss. 5, pp. 971-982
Open Access | Times Cited: 1031
2014 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2014) Vol. 10, Iss. 2
Open Access | Times Cited: 984
Biomarker Modeling of Alzheimer’s Disease
Clifford R. Jack, David M. Holtzman
Neuron (2013) Vol. 80, Iss. 6, pp. 1347-1358
Open Access | Times Cited: 904
A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease
Francesco Panza, Madia Lozupone, Giancarlo Logroscino, et al.
Nature Reviews Neurology (2019) Vol. 15, Iss. 2, pp. 73-88
Open Access | Times Cited: 802
Page 1 - Next Page

Scroll to top